Citigroup’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$366K Buy
133,596
+12,502
+10% +$39.6K ﹤0.01% 3714
2025
Q4
$448K Buy
121,094
+63,982
+112% +$207K ﹤0.01% 3624
2025
Q3
$151K Sell
57,112
-22,942
-29% -$44.4K ﹤0.01% 4109
2025
Q2
$78.8K Sell
80,054
-106,591
-57% -$107K ﹤0.01% 4531
2025
Q1
$269K Sell
186,645
-5,478
-3% -$10.1K ﹤0.01% 4021
2024
Q4
$423K Buy
192,123
+26,119
+16% +$60.9K ﹤0.01% 3949
2024
Q3
$274K Buy
166,004
+115,973
+232% +$234K ﹤0.01% 4130
2024
Q2
$111K Sell
50,031
-306,717
-86% -$722K ﹤0.01% 4160
2024
Q1
$956K Sell
356,748
-21,243
-6% -$51.6K ﹤0.01% 3067
2023
Q4
$1.13M Buy
377,991
+363,058
+2,431% +$471K ﹤0.01% 2722
2023
Q3
$14.6K Sell
14,933
-276
-2% -$399 ﹤0.01% 4466
2023
Q2
$21.1K Sell
15,209
-24,719
-62% -$34.5K ﹤0.01% 4941
2023
Q1
$63.5K Buy
39,928
+24,257
+155% +$125K ﹤0.01% 4189
2022
Q4
$97.6K Buy
15,671
+2,619
+20% +$18.7K ﹤0.01% 4032
2022
Q3
$87K Buy
13,052
+8,031
+160% +$55.2K ﹤0.01% 4159
2022
Q2
$32K Buy
5,021
+1,577
+46% +$8.94K ﹤0.01% 4754
2022
Q1
$16K Sell
3,444
-11,197
-76% -$48K ﹤0.01% 5272
2021
Q4
$73K Buy
14,641
+9,556
+188% +$76.5K ﹤0.01% 4891
2021
Q3
$61K Sell
5,085
-148,288
-97% -$2.16M ﹤0.01% 4636
2021
Q2
$3.24M Sell
153,373
-11,658
-7% -$281K ﹤0.01% 2279
2021
Q1
$4.63M Buy
165,031
+153,969
+1,392% +$4.54M ﹤0.01% 1835
2020
Q4
$288K Sell
11,062
-5,982
-35% -$179K ﹤0.01% 4700
2020
Q3
$634K Sell
17,044
-27,838
-62% -$1.1M ﹤0.01% 3654
2020
Q2
$2.3M Buy
44,882
+12,342
+38% +$516K ﹤0.01% 2659
2020
Q1
$1.03M Buy
32,540
+8,087
+33% +$427K ﹤0.01% 3147
2019
Q4
$1.46M Sell
24,453
-78,893
-76% -$3.55M ﹤0.01% 3331
2019
Q3
$3.79M Sell
103,346
-46,484
-31% -$1.84M 0.01% 2191
2019
Q2
$6.97M Buy
149,830
+133,698
+829% +$6.28M 0.01% 1684
2019
Q1
$647K Sell
16,132
-224,955
-93% -$10.1M ﹤0.01% 3903
2018
Q4
$11.1M Buy
241,087
+126,116
+110% +$6.08M 0.02% 1189
2018
Q3
$5.1M Buy
114,971
+96,214
+513% +$4.42M 0.01% 1843
2018
Q2
$735K Sell
18,757
-614
-3% -$31K ﹤0.01% 3683
2018
Q1
$1.4M Sell
19,371
-46,381
-71% -$3.41M ﹤0.01% 2929
2017
Q4
$4.33M Buy
65,752
+37,200
+130% +$2M 0.01% 1971
2017
Q3
$1.43M Sell
28,552
-28,803
-50% -$1.39M ﹤0.01% 3007
2017
Q2
$2.65M Buy
57,355
+35,949
+168% +$1.32M 0.01% 2292
2017
Q1
$756K Buy
21,406
+10,876
+103% +$249K ﹤0.01% 3503
2016
Q4
$132K Sell
10,530
-3,992
-27% -$47.5K ﹤0.01% 5600
2016
Q3
$201K Buy
14,522
+1,900
+15% +$21.5K ﹤0.01% 4642
2016
Q2
$125K Sell
12,622
-11,926
-49% -$198K ﹤0.01% 4895
2016
Q1
$415K Sell
24,548
-16,188
-40% -$260K ﹤0.01% 4335
2015
Q4
$906K Buy
40,736
+19,363
+91% +$488K ﹤0.01% 3257
2015
Q3
$504K Sell
21,373
-670
-3% -$42K ﹤0.01% 3735
2015
Q2
$1.8M Buy
22,043
+8,600
+64% +$842K ﹤0.01% 2623
2015
Q1
$1.25M Sell
13,443
-4,053
-23% -$262K ﹤0.01% 2911
2014
Q4
$708K Sell
17,496
-1,844
-10% -$56.4K ﹤0.01% 3515
2014
Q3
$473K Buy
19,340
+202
+1% +$3.21K ﹤0.01% 3576
2014
Q2
$303K Buy
19,138
+384
+2% +$5.55K ﹤0.01% 3794
2014
Q1
$284K Sell
18,754
-555
-3% -$8.62K ﹤0.01% 3995
2013
Q4
$265K Buy
19,309
+8,709
+82% +$127K ﹤0.01% 4406
2013
Q3
$200K Buy
+10,600
New +$178K ﹤0.01% 4152

Other funds holding ESPR